IT1194310B - Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti - Google Patents
Derivati triazolo (3,4-a) ftalazinici 3,6-disostituitiInfo
- Publication number
- IT1194310B IT1194310B IT22014/83A IT2201483A IT1194310B IT 1194310 B IT1194310 B IT 1194310B IT 22014/83 A IT22014/83 A IT 22014/83A IT 2201483 A IT2201483 A IT 2201483A IT 1194310 B IT1194310 B IT 1194310B
- Authority
- IT
- Italy
- Prior art keywords
- formula
- ftalazinici
- disostituiti
- triazole derivatives
- alkoxy
- Prior art date
Links
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- -1 3,6-disubstituted-1,2,4-triazolo[3,4-a]phthalazine Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000049 anti-anxiety effect Effects 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22014/83A IT1194310B (it) | 1983-07-12 | 1983-07-12 | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
EP84107562A EP0134946B1 (en) | 1983-07-12 | 1984-06-29 | 3,6-Disubstituted-triazolo[3,4-a]phthalazine derivatives |
AT84107562T ATE28874T1 (de) | 1983-07-12 | 1984-06-29 | 3,6-disubstituierte triazolo(3,4a>phthalazinderivate. |
DE8484107562T DE3465309D1 (de) | 1983-07-12 | 1984-06-29 | 3,6-disubstituted-triazoloû3,4-a¨phthalazine derivatives |
AU30224/84A AU560726B2 (en) | 1983-07-12 | 1984-07-03 | Triazolo(3,4-a)phthalazine and their use as anti-anxiety agents |
DK331884A DK164704C (da) | 1983-07-12 | 1984-07-06 | 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne |
JP59141573A JPS6056982A (ja) | 1983-07-12 | 1984-07-10 | 3,6−ジ置換トリアゾロ〔3,4−a〕フタラジン誘導体、その製法および製薬学的組成物 |
CA000458575A CA1234114A (en) | 1983-07-12 | 1984-07-11 | 3,6-disubstituted triazolo¬3,4-a|phthalazine derivatives |
US06/629,658 US4783461A (en) | 1983-07-12 | 1984-07-11 | 3,6-disubstituted triazolo [3,4-A]phthalazine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22014/83A IT1194310B (it) | 1983-07-12 | 1983-07-12 | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8322014A0 IT8322014A0 (it) | 1983-07-12 |
IT1194310B true IT1194310B (it) | 1988-09-14 |
Family
ID=11190206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT22014/83A IT1194310B (it) | 1983-07-12 | 1983-07-12 | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
Country Status (9)
Country | Link |
---|---|
US (1) | US4783461A (en, 2012) |
EP (1) | EP0134946B1 (en, 2012) |
JP (1) | JPS6056982A (en, 2012) |
AT (1) | ATE28874T1 (en, 2012) |
AU (1) | AU560726B2 (en, 2012) |
CA (1) | CA1234114A (en, 2012) |
DE (1) | DE3465309D1 (en, 2012) |
DK (1) | DK164704C (en, 2012) |
IT (1) | IT1194310B (en, 2012) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000515851A (ja) * | 1996-07-25 | 2000-11-28 | メルク シヤープ エンド ドーム リミテツド | GABA▲下Aα5▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体 |
YU2899A (sh) * | 1996-07-25 | 2000-03-21 | Merck Sharp & Dohme Limited | Supstituisani triazolo-piridazin derivati kao ligandi za gaba receptore |
US6200975B1 (en) | 1997-05-08 | 2001-03-13 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands |
GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
GB9726699D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
GB9723999D0 (en) | 1997-11-13 | 1998-01-14 | Merck Sharp & Dohme | Therapeutic use |
GB9726702D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
US6110915A (en) * | 1997-12-18 | 2000-08-29 | Merck & Co., Inc. | Antiemetic use of triazolo-pyridazine derivatives |
WO1999036423A1 (en) * | 1998-01-14 | 1999-07-22 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for gaba receptors |
GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
IL136442A0 (en) * | 1998-01-21 | 2001-06-14 | Merck Sharp & Dohme | Triazolo-pyridazine derivatives as ligands for gaba receptors |
GB9801208D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801234D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801397D0 (en) | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
CZ291302B6 (cs) | 1998-02-25 | 2003-01-15 | Merck Sharp & Dohme Limited | Substituovaný 1,2,4-triazolo[3,4-a]ftalazinový derivát |
IT1303272B1 (it) * | 1998-10-29 | 2000-11-06 | Zambon Spa | Derivati triciclici inibitori della fosfodiesterasi 4 |
JP2002529468A (ja) | 1998-11-12 | 2002-09-10 | メルク エンド カムパニー インコーポレーテッド | GABA−Aα−5逆活性薬の治療性多形およびそのパモエート組成物 |
GB9824897D0 (en) | 1998-11-12 | 1999-01-06 | Merck Sharp & Dohme | Therapeutic compounds |
CN1390217A (zh) * | 1999-11-12 | 2003-01-08 | 神经原公司 | 二环和三环杂芳族化合物 |
GB0028583D0 (en) | 2000-11-23 | 2001-01-10 | Merck Sharp & Dohme | Therapeutic compounds |
JP5130053B2 (ja) * | 2005-01-05 | 2013-01-30 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | トリアゾロフタラジン |
CN101103033B (zh) * | 2005-01-05 | 2010-08-04 | 尼科梅德有限责任公司 | 作为pde2抑制剂的三唑并酞嗪 |
CA2750458C (en) | 2009-01-29 | 2017-10-24 | Basf Se | Absorbent comprising amino acids and acidic promoter for removing acidic gases |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2484029A (en) * | 1945-12-21 | 1949-10-11 | Ciba Pharm Prod Inc | Hydrazine derivatives of pyridazine compounds |
GB629177A (en) * | 1945-12-21 | 1949-09-14 | Ciba Ltd | Manufacture of new hydrazine compounds and derivatives thereof |
US3711481A (en) * | 1970-04-24 | 1973-01-16 | G Hardtmann | 6-aryl-imidazo(2,1-a)phthalazines |
US3694442A (en) * | 1970-07-28 | 1972-09-26 | William J Houlihan | SUBSTITUTED TETRAHYDRO-1H-PYRAZOLO{8 1,2-b{9 PHTHALAZINES |
US3704300A (en) * | 1971-04-09 | 1972-11-28 | Sandoz Ag | Imidazo(2,1-a)phthalazines |
JPS603080B2 (ja) * | 1976-08-10 | 1985-01-25 | 三菱化学株式会社 | S―トリアゾロ〔3,4 ―α〕〔5,6,7,8〕テトラヒドロ フタラジン類 |
GR70309B (en, 2012) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co | |
FI81350C (fi) * | 1982-01-18 | 1990-10-10 | Lepetit Spa | Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. |
US4391807A (en) * | 1982-07-12 | 1983-07-05 | The Dow Chemical Company | 6-Substituted tetrahydroimidazo[2,1-a]phthalazines and use as bronchodilators |
US4485106A (en) * | 1982-07-12 | 1984-11-27 | The Dow Chemical Company | Substituted tetrahydrotetrazolo[5,1-a]phthalazines |
US4487930A (en) * | 1982-09-07 | 1984-12-11 | The Dow Chemical Company | 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines |
-
1983
- 1983-07-12 IT IT22014/83A patent/IT1194310B/it active
-
1984
- 1984-06-29 EP EP84107562A patent/EP0134946B1/en not_active Expired
- 1984-06-29 AT AT84107562T patent/ATE28874T1/de not_active IP Right Cessation
- 1984-06-29 DE DE8484107562T patent/DE3465309D1/de not_active Expired
- 1984-07-03 AU AU30224/84A patent/AU560726B2/en not_active Ceased
- 1984-07-06 DK DK331884A patent/DK164704C/da not_active IP Right Cessation
- 1984-07-10 JP JP59141573A patent/JPS6056982A/ja active Granted
- 1984-07-11 CA CA000458575A patent/CA1234114A/en not_active Expired
- 1984-07-11 US US06/629,658 patent/US4783461A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IT8322014A0 (it) | 1983-07-12 |
DK331884D0 (da) | 1984-07-06 |
ATE28874T1 (de) | 1987-08-15 |
US4783461A (en) | 1988-11-08 |
DE3465309D1 (de) | 1987-09-17 |
CA1234114A (en) | 1988-03-15 |
AU560726B2 (en) | 1987-04-16 |
AU3022484A (en) | 1985-01-17 |
DK164704C (da) | 1992-12-21 |
JPS6056982A (ja) | 1985-04-02 |
DK331884A (da) | 1985-01-13 |
EP0134946B1 (en) | 1987-08-12 |
JPH051267B2 (en, 2012) | 1993-01-07 |
DK164704B (da) | 1992-08-03 |
EP0134946A1 (en) | 1985-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1194310B (it) | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti | |
DK422583D0 (da) | Fremgangsmade til fremstilling af diazobicyclo-(3,3,1)-nonaner | |
AU7524591A (en) | Nematicidal compositions | |
ES479970A1 (es) | Procedimiento para la obtencion de 5,6-dimetilpirrolo-2,3-d-pirimidinas. | |
CS621987A2 (en) | Coating composition | |
ATE9333T1 (de) | Substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben. | |
ES458481A1 (es) | Un procedimiento de preparacion de nuevos derivados de ben- zodiazepina. | |
ATE46172T1 (de) | Verbindungen, diese enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung. | |
EP0481370A3 (en) | Use of phosphonic acid diglycidylesters as cross-linking agent in hydrogels | |
FI834797A0 (fi) | Foerfarande foer framstaellning av resorcinderivat | |
DE3269505D1 (en) | Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them | |
AU535774B2 (en) | Thiazole derivatives their preparation and pharmaceutical compositions containing them | |
DE3373302D1 (en) | Derivatives of aminopyridinecarboxylic acids, methods for their preparation and pharmaceutical compositions containing them | |
DK159649C (da) | 4-hydroxy-alfa-benzhydrolderivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse, samt fremgangsmaade til fremstilling af disse farmaceutiske praeparater | |
IT1194309B (it) | Derivati 3-fenil-piridazino (4,3-c) isochinolinici | |
SE8701524D0 (sv) | Nya sulfonamider och deras framstellningsforfarande | |
EP0093049A3 (en) | Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them | |
IL70103A0 (en) | Semicarbazides,their preparation and pharmaceutical compositions containing them | |
DE3361834D1 (en) | Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them | |
DK80286A (da) | Hidtil ukendte benzoylurinstofforbindelser, fremgangsmaade til fremstilling heraf samt antitumorkompositioner indeholdende samme |